Key collaboration enables rapid respiratory testing at the point of care
2 May 2025

Heather Danks, Chief Technology Officer at LEX Diagnostics, highlights a key partnership with ZeptoMetrix while developing an ultra-fast thermocycling PCR device for rapid Influenza & SARS-CoV-2 testing. Designed for speed, affordability, and usability, the device enables efficient point-of-care diagnostics. ZeptoMetrix has provided vital support in creating custom controls, working closely with LEX Diagnostics to tailor products to the LEX system. Alongside launching their first product, LEX Diagnostics aims to expand their test menu, setting new standards in patient care.
This video was filmed at ESCMID Global 2025, Vienna, Austria.
About the company
ZeptoMetrix - Molecular Diagnostics
ZeptoMetrix®, an Antylia Scientific company, is your end-to-end diagnostic assay partner in the design, development, and delivery of innovative solutions for the Infectious Disease and Oncology markets. Our expertise and abilities in microbiology, including molecular controls, immunoassay solutions, and microorganisms have set the industry standard for quality and reliability and make ZeptoMetrix the most trusted brand for independent third-party quality controls.


